{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:11:39Z","timestamp":1787803899431,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.metabol.2018.03.011","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T21:24:19Z","timestamp":1521408259000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Insight from mitochondrial functions and proteomics to understand cardiometabolic disorders in survivors of acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"85","author":[{"given":"Jade","family":"Leahy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schohraya","family":"Spahis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bonneil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Grimard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Laverdi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Krajinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgard","family":"Delvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sinnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Marcil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2018.03.011_bb0005","series-title":"Canadian cancer statistics 2017","author":"Statistics CCSsACoC","year":"2017"},{"key":"10.1016\/j.metabol.2018.03.011_bb0010","first-page":"83","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.metabol.2018.03.011_bb0015","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2165\/00003495-200767150-00004","article-title":"Treatment of acute lymphoblastic leukaemia: a new era","volume":"67","author":"Apostolidou","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2018.03.011_bb0020","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.03.011_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/1055-9965.EPI-09-0555","article-title":"Cardiovascular risk factors in adult survivors of pediatric cancer\u2013a report from the childhood cancer survivor study","volume":"19","author":"Meacham","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2018.03.011_bb0030","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cncr.22120","article-title":"Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia","volume":"107","author":"Gurney","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.metabol.2018.03.011_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00043426-200110000-00007","article-title":"Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia","volume":"23","author":"Oeffinger","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.metabol.2018.03.011_bb0040","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1200\/JCO.2008.19.7251","article-title":"Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia","volume":"27","author":"Oeffinger","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2018.03.011_bb0045","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1210\/jc.2006-2178","article-title":"Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia","volume":"92","author":"Janiszewski","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.03.011_bb0050","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1194\/jlr.P029785","article-title":"Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia","volume":"53","author":"Malhotra","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2018.03.011_bb0055","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1194\/jlr.M072207","article-title":"Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors","volume":"58","author":"Morel","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2018.03.011_bb0060","first-page":"184","article-title":"Mitochondrial dysfunction in DDR-related cancer predisposition syndromes","volume":"1865","author":"Lyakhovich","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2018.03.011_bb0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1741-7007-12-34","article-title":"Mitochondria as signaling organelles","volume":"12","author":"Chandel","year":"2014","journal-title":"BMC Biol"},{"key":"10.1016\/j.metabol.2018.03.011_bb0070","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/mnfr.200700075","article-title":"Medication-induced mitochondrial damage and disease","volume":"52","author":"Neustadt","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.metabol.2018.03.011_bb0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejcsup.2014.03.002","article-title":"Cardiovascular disease after cancer therapy","volume":"12","author":"Aleman","year":"2014","journal-title":"EJC Suppl"},{"key":"10.1016\/j.metabol.2018.03.011_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-8722-5-11","article-title":"Comparative mitochondrial proteomics: perspective in human diseases","volume":"5","author":"Jiang","year":"2012","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.metabol.2018.03.011_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-genom-082509-141720","article-title":"The mitochondrial proteome and human disease","volume":"11","author":"Calvo","year":"2010","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.metabol.2018.03.011_bb0090","article-title":"Proteomics of mammalian mitochondria in health and malignancy: from protein identification to function","author":"Eremina","year":"2017","journal-title":"Anal Biochem"},{"key":"10.1016\/j.metabol.2018.03.011_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mito.2016.07.006","article-title":"Proteomics of human mitochondria","volume":"33","author":"Palmfeldt","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.metabol.2018.03.011_bb0100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.biochem.76.052705.163409","article-title":"Translocation of proteins into mitochondria","volume":"76","author":"Neupert","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.metabol.2018.03.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26361","article-title":"The PETALE study: late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors","volume":"64","author":"Marcoux","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.metabol.2018.03.011_bb0110","first-page":"569","article-title":"Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"32","author":"Leung","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.metabol.2018.03.011_bb0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-60761-842-3_13","article-title":"Protein quantitation using mass spectrometry","volume":"673","author":"Zhang","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.metabol.2018.03.011_bb0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000335675","article-title":"Mitochondria and oxidative stress in the cardiorenal metabolic syndrome","volume":"2","author":"Aroor","year":"2012","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.metabol.2018.03.011_bb0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yexmp.2006.09.008","article-title":"Mitochondrial dysfunction and molecular pathways of disease","volume":"83","author":"Pieczenik","year":"2007","journal-title":"Exp Mol Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2018.03.011_bb0130","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.2337\/diabetes.53.2007.S110","article-title":"Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes","volume":"53","author":"Green","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.03.011_bb0135","first-page":"25","article-title":"Mitochondrial medicine\u2013molecular pathology of defective oxidative phosphorylation","volume":"31","author":"Fosslien","year":"2001","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.metabol.2018.03.011_bb0140","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2741\/4420","article-title":"Mitochondrial anomalies: driver to age associated degenerative human ailments","volume":"21","author":"Bunkar","year":"2016","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.metabol.2018.03.011_bb0145","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2337\/diabetes.53.6.1412","article-title":"Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes","volume":"53","author":"Schrauwen","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.03.011_bb0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11892-008-0030-1","article-title":"Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus","volume":"8","author":"Abdul-Ghani","year":"2008","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.metabol.2018.03.011_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mito.2015.01.006","article-title":"Mitochondrial dependency in progression of acute myeloid leukemia","volume":"21","author":"Basak","year":"2015","journal-title":"Mitochondrion"},{"key":"10.1016\/j.metabol.2018.03.011_bb0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2018.03.011_bb0165","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr Biol"},{"key":"10.1016\/j.metabol.2018.03.011_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/bse0470069","article-title":"Regulation of mitochondrial biogenesis","volume":"47","author":"Jornayvaz","year":"2010","journal-title":"Essays Biochem"},{"key":"10.1016\/j.metabol.2018.03.011_bb0175","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10545-012-9480-3","article-title":"Mitochondrial proteomics\u2013a tool for the study of metabolic disorders","volume":"35","author":"Gregersen","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.metabol.2018.03.011_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086994","article-title":"Galectin-1 in early acute myocardial infarction","volume":"9","author":"Al-Salam","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.03.011_bb0185","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1073\/pnas.1032913100","article-title":"Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1","volume":"100","author":"Patti","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2018.03.011_bb0190","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/pmic.201300376","article-title":"Mitochondria in metabolic disease: getting clues from proteomic studies","volume":"14","author":"Peinado","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.metabol.2018.03.011_bb0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5830\/CVJA-2010-058","article-title":"Proteomic analysis of mitochondrial proteins in a mouse model of type 2 diabetes","volume":"22","author":"Essop","year":"2011","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.metabol.2018.03.011_bb0200","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.lfs.2009.02.026","article-title":"Oxidative stress and metabolic syndrome","volume":"84","author":"Roberts","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.metabol.2018.03.011_bb0205","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/j.orcp.2013.05.004","article-title":"Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer","volume":"7","author":"Matsuda","year":"2013","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.metabol.2018.03.011_bb0210","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2018.03.011_bb0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.numecd.2009.06.002","article-title":"A novel component of the metabolic syndrome: the oxidative stress","volume":"20","author":"Hopps","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2018.03.011_bb0220","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/ijms16010378","article-title":"Oxidative stress in obesity: a critical component in human diseases","volume":"16","author":"Marseglia","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2018.03.011_bb0225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10565-018-9425-1","article-title":"The role of mitochondria in cellular toxicity as a potential drug target","volume":"34","author":"Wu","year":"2018","journal-title":"Cell Biol Toxicol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049518300830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049518300830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:17:40Z","timestamp":1758428260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049518300830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":45,"alternative-id":["S0026049518300830"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2018.03.011","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight from mitochondrial functions and proteomics to understand cardiometabolic disorders in survivors of acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2018.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}